Drug Designing

Drug designing is an inventive process of finding new medication based on the target knowledge. A drug is commonly a small compound which produces a therapeutic effect. There are different methods of drug designing. Designing a drug based on the three dimensional structure and computational techniques are known as structure based drug design and computer aided drug design respectively. There are various stages involved in computer aided drug design such as hit identification, hit to lead optimization and lead optimization. In structure based drug design, the structure is obtained either through x-ray crystallography or NMR spectroscopy. Ligand-based drug design depends on the knowledge of molecules that bind to the biological target of our interest. Correlation between calculated and theoretical can be derived and this QSAR relationship is used to derive analogs.

  • Structure Based Drug Design
  • Ligand Based Drug Design
  • Drug Interactions
  • Virtural Screening and Drug Design
  • Computation Biology for Drug Target Identification and Validation
  • Nanomedicine

Related Conference of Drug Designing

February 22-23, 2023

International Bio Summit and Expo

London, UK
April 17-18, 2023

13th World Glycobiology Congress

Rome, Italy
June 19-20, 2023

5th International Conference on Biochemistry

London, UK
June 19-20, 2023

5th International Conference on Nucleic Acids

London, UK
June 27-28, 2023

13th Annual Summit on Advanced Bionics

Vienna, Austria
September 21-22, 2023

19th World Congress on Structural Biology

Paris, France
September 21-22, 2023

14th International Conference on Biofuels and Bioenergy

Toronto, Canada
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy
November 01-02, 2023

19th International Conference on Metabolomics

Rome, Italy

Drug Designing Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in